Auna S.A. plans additional senior notes offering

MONTERREY, Mexico - Auna S.A. (NYSE: AUNA), a healthcare provider with a network across Mexico, Peru, and Colombia, currently trading at $6.97 near its 52-week low, announced its intention to offer additional senior secured notes due 2029 in a private offering aimed at qualified institutional buyers. According to InvestingPro analysis, the company appears undervalued based on its Fair Value calculation, with analysts projecting net income growth this year. These notes, with an interest rate of 10.000%, will join the existing issuance under the same terms, except for their issuance date, issue price, and initial interest payment date.

The company’s subsidiaries will fully and unconditionally guarantee the additional notes on a senior secured basis. The precise timing and terms of the offering will hinge on market conditions and other factors. With a debt-to-equity ratio of 2.64 and current ratio of 0.88, Auna plans to use the proceeds to partially prepay existing credit agreement debts from November 10, 2023, and cover related interests, fees, and expenses. InvestingPro subscribers can access detailed financial health metrics and 5 additional ProTips about AUNA’s debt management and growth prospects.

This private offering falls under Rule 144A of the Securities Act of 1933, as amended, and Regulation S for non-U.S. persons. The securities involved have not been registered under the Securities Act or any state securities laws and will not be available for sale in the United States without registration or an applicable exemption from such registration requirements.

Auna, founded in 1989, operates one of Latin America’s largest healthcare platforms, focusing on high-complexity diseases and prevention. The company generates annual revenue of $1.16 billion with an EBITDA of $251.64 million. As of December 31, 2024, Auna’s network included 31 healthcare facilities and 1.4 million healthcare plans.

The press release also contains forward-looking statements regarding the additional notes offering and its expected use of proceeds. However, investors are cautioned that these statements are subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from those projected.

This news article is based on a press release statement from Auna S.A.

In other recent news, Auna SAA ADR reported its fourth-quarter earnings for 2024, which fell short of analyst expectations. The company recorded earnings per share (EPS) of $0.1284, missing the forecasted $0.1419, while revenue was $290.45 million against an expected $297.95 million. Despite the shortfall, Auna demonstrated robust year-over-year growth with a Q4 revenue of PEN 1.1 billion, marking an 11% increase in foreign exchange-neutral terms. Full-year revenue reached PEN 4.4 billion, up 12%, and adjusted EBITDA for the quarter grew by 28%, with full-year figures showing a 20% increase to PEN 993 million. The company remains focused on expanding its healthcare services in Latin America and aims for 20% EBITDA growth internally, although it expresses caution due to uncertainties in the Colombian market. Auna has also announced plans to expand its operations in Mexico and Peru, emphasizing high-complexity healthcare services. Analyst feedback from firms like Morgan Stanley highlighted these developments, indicating both challenges and growth opportunities for the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.